1. Home
  2. WKHS vs PSTV Comparison

WKHS vs PSTV Comparison

Compare WKHS & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$2.99

Market Cap

40.3M

ML Signal

HOLD

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$5.01

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
PSTV
Founded
2007
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.3M
37.2M
IPO Year
2008
2016

Fundamental Metrics

Financial Performance
Metric
WKHS
PSTV
Price
$2.99
$5.01
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$21.00
$55.00
AVG Volume (30 Days)
170.7K
130.2K
Earning Date
05-14-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
86.92
87.61
EPS
N/A
N/A
Revenue
$763,173.00
$5,213,000.00
Revenue This Year
$89.23
$13.20
Revenue Next Year
$28.84
$261.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.13
52 Week High
$11.80
$8.00

Technical Indicators

Market Signals
Indicator
WKHS
PSTV
Relative Strength Index (RSI) 43.44 42.17
Support Level $2.81 $0.37
Resistance Level $4.18 $6.65
Average True Range (ATR) 0.37 0.47
MACD -0.08 -0.14
Stochastic Oscillator 3.75 3.45

Price Performance

Historical Comparison
WKHS
PSTV

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: